ACO Name and Location
- Privia Medical Group Gulf Coast PLLC
- 950 N Glebe Rd Suite 700
- Arlington, VA 22203
ACO Primary Contact
Lynne Vaassen
Phone: 713-512-7001
Email: lvaassen@priviahealth.com
Organizational Information
ACO Participants:
| ACO Participants | ACO Participant in Joint Venture |
|---|---|
| Benjamin Adam Stahl M.D., P.A. | N |
| Camille Goff | N |
| Cheryl Clark-Brown | N |
| Complete Care Obgyn And Family Medicine PLLC | N |
| Doctors Clinic Of Spokane P S | N |
| Edward Kuo, M.D., P.A. | N |
| Family Medicine Associates Of Conroe PLLC | N |
| Family Practice Associates, P.A. | N |
| Gary L. Gilcrease M.D., P.A. | N |
| Hospital Internists Of Texas Clinic PLLC | N |
| Jennifer Gwozdz | N |
| Lewis Family Medicine | N |
| Lori Naglieri, M.D., P.A. | N |
| Medina Lake Clinic P.A. | N |
| Narendra Punjabi M.D., P.A. | N |
| Privia Medical Group Gulf Coast PLLC | N |
| Privia Medical Group West Texas PLLC | N |
| San Antonio Family Physicians | N |
| Spangler Medical Enterprises, P.A. | N |
| St. Elizabeth Family Care, LLC | N |
| Waco Primary Care, P.A. | N |
| Walla Walla Clinic, Inc. | N |
ACO Governing Body:
| Member First Name | Member Last Name | Member Title/Position | *Member’s Voting Power – Expressed as a percentage | Membership Type | ACO Participant TIN Legal Business Name/DBA, if Applicable |
|---|---|---|---|---|---|
| Keith | Fernandez, MD | Director | 6.250% | ACO Executive | N/A |
| Stephen | Cone | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Mark | Florian | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Thimos | Paschalis | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Christopher | Prihoda | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Susan | Vogel | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Daniel | Dawson | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Alan | Lee | Director | 10.714% | ACO Participant Representative | Privia Medical Group Gulf Coast PLLC |
| Lynne | Vaassen | Director | 6.250% | VP Population Health, Privia Health | N/A |
| David | Dunwoody | Director | 6.250% | Medicare Beneficiary Representative | N/A |
| Evan | Varadi | Director | 6.250% | RVP Practice Operations, Privia Health | N/A |
* –Due to rounding, ‘Member’s Voting Power’ may not equal 100 percent.
Key ACO Clinical and Administrative Leadership:
- ACO Executive: Keith Fernandez, MD
- Medical Director: Keith Fernandez, MD
- Compliance Officer: Stephanie Clark
- Quality Assurance/Improvement Officer: Elizabeth Lekas
Associated Committees and Committee Leadership:
| Committee Name | Committee Leader Name & Position |
|---|---|
| Finance Committee | David Mountcastle |
| Quality Assurance Committee | Christopher Prihoda, M.D. – Chair |
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Second Agreement Period
- Performance Year 2024: $20,023,801.22
- Performance Year 2023: $9,610,568.36
- Performance Year 2022: $7,631,504.64
- First Agreement Period
- Performance Year 2021: $5,344,749.41
- Performance Year 2020: $5,091,075.46
- Performance Year 2019: $2,470,186.33
- Performance Year 2018: $4,203,425
Shared Savings Distribution
-
- Second Agreement Period
- Performance Year 2024
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2023
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2022
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2024
- First Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2019
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- Proportion invested in infrastructure: 45%
- Proportion invested in redesigned care processes/resources: 5%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2021
- Second Agreement Period
Quality Performance Results
2024 Quality Performance Results:
Quality Performance Results are based on CMS Web Interface Measure Set
| Measure # | Measure Name | Collection Type | Reported Performance Rate | Current Year Mean Performance Rate (SSP ACOs) |
|---|---|---|---|---|
| Measure # 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | CMS Web Interface | 3.10 | 9.44 |
| Measure # 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 84.43 | 81.46 |
| Measure # 236 | Controlling High Blood Pressure | CMS Web Interface | 78.15 | 79.49 |
| Measure # 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 99.60 | 88.99 |
| Measure # 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 70.53 | 68.60 |
| Measure # 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 94.74 | 79.98 |
| Measure # 113 | Colorectal Cancer Screening | CMS Web Interface | 76.02 | 77.81 |
| Measure # 112 | Breast Cancer Screening | CMS Web Interface | 81.50 | 80.93 |
| Measure # 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 80.97 | 86.50 |
| Measure # 370 | Depression Remission at Twelve Months | CMS Web Interface | 25.81 | 17.35 |
| Measure # 321 | CAHPS for MIPS | CMS Web Interface | 7.97 | 6.67 |
| Measure # 479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | CMS Web Interface | 0.1520 | 0.1517 |
| Measure # 484 | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | CMS Web Interface | — | 37.00 |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 83.92 | 83.70 |
| CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 94.26 | 93.96 |
| CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 92.44 | 92.43 |
| CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 77.96 | 75.76 |
| CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 72.71 | 65.48 |
| CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 65.87 | 62.31 |
| CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 75.98 | 74.14 |
| CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 86.23 | 85.89 |
| CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 94.04 | 92.89 |
| CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 30.25 | 26.98 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov
